We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

22 hedge funds and large institutions have $54.4M invested in Albireo Pharma Inc in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

9% more capital invested

Capital invested by funds: $50M → $54.4M (+$4.38M)

8% less funds holding

Funds holding: 24 → 22 (-2)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
22
Holders Change
-2
Holders Change %
-8.33%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.08M
2
Deutsche Bank
Deutsche Bank
Germany
+$1.57M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$126K
4
SFM
Sphera Funds Management
Israel
+$119K
5
BlackRock
BlackRock
New York
+$46.6K

Top Sellers

Rank Fund Capital Flow
1
SAM
Sectoral Asset Management
Quebec, Canada
-$732K
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$573K
3
Renaissance Technologies
Renaissance Technologies
New York
-$236K
4
Northern Trust
Northern Trust
Illinois
-$204K
5
PVH
Psagot Value Holdings
Israel
-$49K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$17.7M – – –
TGHSA
2
TPG Group Holdings (SBS) Advisors
Texas
$16.3M – – –
BBA
3
Baker Bros. Advisors
New York
$4.19M – – –
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$3.91M +$4.08M +171,098 +1,101%
SAM
5
Sectoral Asset Management
Quebec, Canada
$3.31M -$732K -30,685 -16%
Renaissance Technologies
6
Renaissance Technologies
New York
$2.84M -$236K -9,900 -7%
SFM
7
Sphera Funds Management
Israel
$2.27M +$119K +5,000 +5%
Deutsche Bank
8
Deutsche Bank
Germany
$1.43M +$1.57M +65,660 +2,736%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$667K +$126K +5,303 +20%
Vanguard Group
10
Vanguard Group
Pennsylvania
$628K -$12.1K -506 -2%
Millennium Management
11
Millennium Management
New York
$590K -$43.3K -1,814 -6%
JMH
12
J.M. Hartwell
New York
$318K – – –
BlackRock
13
BlackRock
New York
$229K +$46.6K +1,955 +22%
Wells Fargo
14
Wells Fargo
California
$35K +$39.6K +1,662 New
Morgan Stanley
15
Morgan Stanley
New York
$10K +$10.9K +457 New
Manulife (Manufacturers Life Insurance)
16
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$7K +$7.08K +297 +582%
JP Morgan Chase
17
JP Morgan Chase
New York
$4K +$4.77K +200 New
Bank of America
18
Bank of America
North Carolina
$1K -$2.12K -89 -65%
LTFS
19
Ladenburg Thalmann Financial Services
Florida
$1K – – –
PMFA
20
Plante Moran Financial Advisors
Michigan
$1K – – –
TRCT
21
Tower Research Capital (TRC)
New York
$1K +$1K +42 New
Alyeska Investment Group
22
Alyeska Investment Group
Illinois
– -$573K -27,796 Closed
Northern Trust
23
Northern Trust
Illinois
– -$204K -9,886 Closed
PVH
24
Psagot Value Holdings
Israel
– -$49K -2,367 Closed
NSIM
25
North Star Investment Management
Illinois
– -$1K -33 Closed

ALBO Hedge Fund Activity: Q3 2017 in Review

22 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q3 2017, worth a combined $54.4M — up 8.8% from $50M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ALBO and 4 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 6 added.

The largest buyer was Point72 Asset Management, adding an estimated $4.08M. The largest seller was Sectoral Asset Management, cutting an estimated $732K.

  • 22 institutional investors held Albireo Pharma Inc (ALBO) as of Q3 2017, down from 24 in Q2 2017.
  • Funds reported $54.4M of Albireo Pharma Inc stock for Q3 2017, up 8.8% quarter-over-quarter.
  • 4 funds opened new Albireo Pharma Inc positions in Q3 2017 and 6 closed out, a net change of -2 holders.
  • The largest Albireo Pharma Inc buyer in Q3 2017 was Point72 Asset Management, an estimated $4.08M added.
  • The largest Albireo Pharma Inc seller in Q3 2017 was Sectoral Asset Management, an estimated $732K sold.

Based on aggregated 13F filings for Q3 2017.